Genmab(GMAB) - 2023 Q4 - Earnings Call Transcript

James Gordon - JPMorgan Chase & Co Kaveri Pohlman - BTIG Peter Verdult - Citigroup Inc Sachin Jain - BofA Securities Jonathan Chang - Leerink Paul Jeng - Guggenheim Securities Peter Welford - Jefferies Genmab A/S (GMAB) Q4 2023 Results Conference Call February 14, 2024 12:00 PM ET Company Participants Jan van de Winkel - Co-Founder, President and Chief Executive Officer Anthony Mancini - Executive Vice President & COO Anthony Pagano - Executive Vice President & CFO Tahi Ahmadi Genmab - Executive VP, Chief M ...